Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 16;15(8):e43606.
doi: 10.7759/cureus.43606. eCollection 2023 Aug.

Effect of Arsenate and p-Phenylenediamine on the Expression of Aquaporins in Cultured Human Urothelial Cells

Affiliations

Effect of Arsenate and p-Phenylenediamine on the Expression of Aquaporins in Cultured Human Urothelial Cells

Yi-Hsiao Wu et al. Cureus. .

Abstract

Background: Exposure to arsenic (As) or p‑phenylenediamine (PPD) can lead to dysfunction, or even cancer, in various types of organs, including the urinary bladder, yet the underlying mechanisms remain unclear. Aquaporins (AQPs) are widely expressed small water channel proteins that provide the major route for the transport of water and other small molecules across plasma membranes in diverse cell types. Altered expression of AQPs has been associated with pathologies in all major organs, including the urinary bladder.

Objective: The present in vitro study was performed as a first step towards exploring the possible involvement of AQPs in As- and PPD‑induced bladder diseases.

Methods: An immortalized normal human urothelial cell line was employed. Cells were exposed to different concentrations of sodium arsenate (0‑20 μM) or PPD (0‑200 μM) for 48 h. Cell viability was subsequently assessed. The mRNA and protein expression levels of AQPs (specifically, AQP3, 4, 7, 9, and 11) were analyzed using reverse transcription‑quantitative polymerase chain reaction and Western blot analyses, respectively.

Results: The viability of the cells was decreased in a concentration-dependent manner upon exposure to arsenate. The mRNA and protein expression levels of AQP3, 4, 7, and 9 were substantially reduced, whereas the expression of AQP11 was largely unchanged. As for the experiments with PPD, treatment with increasing concentrations of PPD induced a gradual decrease in cell viability. The mRNA and protein expression levels of AQP3, 4, and 11 were generally unaltered; however, a marked reduction in the expression levels of AQP7 was observed, contrasting with a gradual concentration-dependent decrease in the expression of AQP9.

Conclusion: The importance of the differential expression profiles of the AQPs induced by arsenate and PPD requires further investigation; nevertheless, the findings of the present study suggest that AQPs have a role in As‑ and PPD‑induced bladder diseases.

Keywords: aquaporin; arsenate; p-phenylenediamine; urinary bladder; urothelial cell.

PubMed Disclaimer

Conflict of interest statement

The authors have declared financial relationships, which are detailed in the next section.

Figures

Figure 1
Figure 1. Effect of sodium arsenate on the cell viability and expression levels of AQP3 and AQP4 in SV-HUC1 cells.
(A) Cell viability. The data are presented as the mean ± SEM for three independent experiments. (B, D) RT‑qPCR analysis was used to examine the effect of arsenate on the mRNA expression levels of AQP3 and AQP4. The results are shown as the mean ± SEM for data from four different experiments, and the expression levels were normalized against that of the housekeeping gene, GAPDH. (C, E) Western blot analysis was used to detect the effect of arsenate on the protein expression levels of AQP3 and AQP4. The expression levels were normalized against that of β‑actin. *P<0.05 compared with control (0 µM As). AQP: aquaporin, SEM: standard error of the mean, RT-qPCR: reverse transcription-quantitative polymerase chain reaction
Figure 2
Figure 2. Effect of sodium arsenate on the expression levels of AQP7, 9, and 11 in SV-HUC1 cells.
(A, C, E) RT‑qPCR analysis of AQP7, AQP9, and AQP11. The results are shown as the mean ± SEM for data from four different experiments, and the expression levels were normalized against that of the housekeeping gene, GAPDH. (B, D, F) Western blot analysis was used to detect the protein expression levels of AQP7, AQP9, and AQP11. The expression level was normalized against that of β‑actin. *P<0.05 vs. control (0 µM As); #P<0.05 vs. 10 µM. AQP: aquaporin, SEM: standard error of the mean, RT-qPCR: reverse transcription-quantitative polymerase chain reaction
Figure 3
Figure 3. Effect of PPD on the cell viability and expression levels of AQP3 and AQP4 in SV-HUC1 cells.
(A) Cell viability. Data are shown as the mean ± SEM of three independent experiments. (B, D) RT‑qPCR analysis was used to examine the effect of PPD on the mRNA expression levels of AQP3 and AQP4. The results shown are the mean ± SEM for data from four different experiments, and the expression levels were normalized against that of the housekeeping gene, GAPDH. (C, E) Western blot analysis was used to detect the effect of PPD on the protein expression levels of AQP3 and AQP4. The expression levels were normalized against that of β‑actin. *P<0.05 vs. control (0 µM PPD). AQP: aquaporin, SEM: standard error of the mean, RT-qPCR: reverse transcription-quantitative polymerase chain reaction, PPD: p-phenylenediamine
Figure 4
Figure 4. Effect of PPD on the expression levels of AQP7, 9, and 11 in SV-HUC1 cells.
(A, C, E) RT‑qPCR analysis of AQP7, AQP9, and AQP11. The results are shown as the mean ± SEM for data from four different experiments, and the expression levels were normalized against that of the housekeeping gene, GAPDH. (B, D, F) Western blot analysis was used to detect the protein expression levels of AQP7, AQP9, and AQP11. The expression levels were normalized against that of β‑actin. *P<0.05 vs. control (0 µM PPD); #P<0.05 vs. 50 µM PPD. AQP: aquaporin, SEM: standard error of the mean, RT-qPCR: reverse transcription-quantitative polymerase chain reaction, PPD: p-phenylenediamine

References

    1. Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective. Tseng CH. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007;25:1–22. - PubMed
    1. Health effects of chronic arsenic exposure. Hong YS, Song KH, Chung JY. J Prev Med Public Health. 2014;47:245–252. - PMC - PubMed
    1. Metabolism, toxicity and anticancer activities of arsenic compounds. Khairul I, Wang QQ, Jiang YH, Wang C, Naranmandura H. Oncotarget. 2017;8:23905–23926. - PMC - PubMed
    1. Pathways of arsenic uptake and efflux. Garbinski LD, Rosen BP, Chen J. Environ Int. 2019;126:585–597. - PMC - PubMed
    1. Environmental arsenic exposure and its contribution to human diseases, toxicity mechanism and management. Rahaman MS, Rahman MM, Mise N, et al. Environ Pollut. 2021;289:117940. - PubMed

LinkOut - more resources